sample review
- BMA anti-TR7 antibody was used to perform immunohistochemistry in order to study the role of the LT beta receptor pathway play in the aorta adventitia of aged ApoE-/- mice.
- BMA Biomedicals monoclonal anti-MRP14 antibody (S36.48) was used in immunohistochemistry to determine whether the heterogeneous clinical response to tumour necrosis factor (TNF) alpha blocking therapy in rheumatoid arthritis (RA) can be predicted by TNFalpha expression in the synovium before initiation of treatment.
- BMA Biomedicals monoclonal anti-myeloid related protein (MRP) 8 antibody (8-5c2) was used in immunohistochemistry to determine whether the heterogeneous clinical response to tumour necrosis factor (TNF) alpha blocking therapy in rheumatoid arthritis (RA) can be predicted by TNFalpha expression in the synovium before initiation of treatment.
- BMA Biomedicals AG rat monoclonal anti-CD18 antigen antibody was used in immunohistochemistry to study the role for hemopexin in preventing endothelial damage and liver congestion in a mouse model of heme overload.
- BMA Biomedicals monoclonal anti-MRP14 antibodies (S36.48 and 2, 70E+11) were used in immunohistochemistry to study the effects of the C5aR blockade on synovial inflammation in RA patients.
- BMA Biomedicals monoclonal anti-MRP8 antibodies (8-5C2 and 2, 70E+11) were used in immunohistochemistry to study the effects of the C5aR blockade on synovial inflammation in RA patients.
- BMA Biomedicals AG anti-CD46 SCR I antibody 13/42 was used in human A549 cells and in flow cytometry to study the interaction between Ad35 and CD46.
- BMA chicken BRI2 IgY polyclonal antibody was used in western blot and immunoprecipitation to investigate the binding of BRI2 to APP precursor protein.